IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study.
Bioretec's ActivaPin bioresorbable implant provides good alternative treatment of pediatric elbow injuries
BerGenBio reports second quarter and half year 2022 financial results and provides business update (2)
BerGenBio reports second quarter and half year 2022 financial results and provides business update (1)